1-201074522-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000069.3(CACNA1S):​c.2047C>T​(p.Arg683Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00172 in 1,612,280 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R683H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0091 ( 20 hom., cov: 34)
Exomes 𝑓: 0.00096 ( 20 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

2
11
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.27
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008310705).
BP6
Variant 1-201074522-G-A is Benign according to our data. Variant chr1-201074522-G-A is described in ClinVar as [Benign]. Clinvar id is 199685.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00906 (1381/152346) while in subpopulation AFR AF= 0.0316 (1312/41570). AF 95% confidence interval is 0.0301. There are 20 homozygotes in gnomad4. There are 619 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CACNA1SNM_000069.3 linkuse as main transcriptc.2047C>T p.Arg683Cys missense_variant 14/44 ENST00000362061.4
CACNA1SXM_005245478.4 linkuse as main transcriptc.2047C>T p.Arg683Cys missense_variant 14/43

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CACNA1SENST00000362061.4 linkuse as main transcriptc.2047C>T p.Arg683Cys missense_variant 14/441 NM_000069.3 P2

Frequencies

GnomAD3 genomes
AF:
0.00906
AC:
1379
AN:
152228
Hom.:
20
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0316
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00669
GnomAD3 exomes
AF:
0.00247
AC:
620
AN:
250924
Hom.:
6
AF XY:
0.00168
AC XY:
228
AN XY:
135612
show subpopulations
Gnomad AFR exome
AF:
0.0331
Gnomad AMR exome
AF:
0.00174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.000959
AC:
1400
AN:
1459934
Hom.:
20
Cov.:
31
AF XY:
0.000847
AC XY:
615
AN XY:
726344
show subpopulations
Gnomad4 AFR exome
AF:
0.0324
Gnomad4 AMR exome
AF:
0.00188
Gnomad4 ASJ exome
AF:
0.0000766
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0000929
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000101
Gnomad4 OTH exome
AF:
0.00171
GnomAD4 genome
AF:
0.00906
AC:
1381
AN:
152346
Hom.:
20
Cov.:
34
AF XY:
0.00831
AC XY:
619
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.0316
Gnomad4 AMR
AF:
0.00294
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00117
Hom.:
5
Bravo
AF:
0.0106
ESP6500AA
AF:
0.0284
AC:
125
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00291
AC:
353
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypokalemic periodic paralysis, type 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Malignant hyperthermia, susceptibility to, 5 Benign:2
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Malignant hyperthermia of anesthesia Benign:1
Benign, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaOct 01, 2015- -
Congenital myopathy 18 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Thyrotoxic periodic paralysis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 07, 2019- -
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.13
T;D
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.95
D;D
MetaRNN
Benign
0.0083
T;T
MetaSVM
Uncertain
0.47
D
MutationAssessor
Uncertain
2.8
.;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.53
T
PROVEAN
Pathogenic
-6.2
D;D
REVEL
Uncertain
0.60
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
.;D
Vest4
0.67
MVP
0.96
MPC
0.61
ClinPred
0.046
T
GERP RS
4.0
Varity_R
0.26
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35708442; hg19: chr1-201043650; API